Gastrointestinal Cancer News

President Joe Biden today announced his intention to appoint oncologist, researcher and educator, W. Kimryn Rathmell, MD, PhD, as director of the NCI.

Cancer-related mortality and leading causes of cancer death occurred more frequently in nonmetropolitan areas and among individuals with limited education, according to biennial report from the American Cancer Society.

The FDA approved pembrolizumab for use with chemotherapy to treat HER2-negative gastric or gastroesophageal junction adenocarcinoma.

The number of cancer surgeries, chemotherapy treatments and radiation treatments declined dramatically during the first months of the COVID-19 pandemic, study findings published in JAMA Oncology showed.

Over 10% of fecal immunochemical tests used for routine colorectal cancer screening contained unsatisfactory samples that could not be processed, according to study findings published in Cancer Epidemiology, Biomarkers and Prevention.

Risk for developing colorectal cancer increased by 47% among individuals with type 2 diabetes, according to results from a cohort study designed to over-represent African Americans and low-income patients.

BOSTON — Transarterial chemoembolization with vitamin K dosing improved anticancer outcomes of objective response and progression-free survival in patients with hepatocellular carcinoma, according to a researcher at The Liver Meeting.

Anti-PD-1 therapy reduces de novo production of spike-specific antibodies following vaccination from SARS-CoV-2, according to study findings presented at Society for Immunotherapy of Cancer Annual Meeting.

Durvalumab combined with transarterial chemoembolization and bevacizumab lengthened PFS among certain patients with hepatocellular carcinoma, according to the agent’s manufacturer.

A virtual town hall meeting featuring a panel of regulatory, pharmacy and procurement experts addressed the ongoing shortage of oncology drugs.